易聯眾(300096.SZ):擬掛牌轉讓所持電子科技51%股權
格隆匯9月13日丨易聯眾(300096.SZ)公佈,因電子科技主營業務與公司整體發展戰略不一致,且與公司各業務板塊無法構成協同互補作用,基於目前公司的實際經營情況,為落實公司戰略規劃,優化資源配置,公司擬將持有的電子科技51%的股權與張曦所持有的電子科技17%的股權聯合在福建省產權交易中心以公開掛牌的方式進行轉讓。
公司所持有的電子科技51%的股權首次掛牌價格不低於551.69萬元,張曦所持有的電子科技17%的股權首次掛牌價格不低於183.9萬元,最終轉讓價格以實際掛牌成交價為準。
本次股權掛牌轉讓完成後,公司將不再持有電子科技股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.